In its first major mandate for The Carlyle Group in recent years, Freshfields Bruckhaus Deringer has advised as the private equity firm picked up chemicals firm Atotech from Total for $3.2bn. Continue reading “Freshfields lands major Carlyle deal with $3.2bn Atotech acquisition”
Pinsents and Linklaters act on latest big pharma deal as Teva sells Allergan generics business for £600m
Pinsent Masons and Linklaters are advising on Teva Pharmaceutical Industries’ sale of UK and Ireland business Activas Generics for £603m as the Israeli firm seeks to divest assets following last year’s takeover of Allergan.
Herbert Smith Freehills and Ashurst get the call up for O2’s listing
Herbert Smith Freehills (HSF) and Ashurst have won roles advising Telefonica on its plans for an initial public offering (IPO) of its UK business O2.
Continue reading “Herbert Smith Freehills and Ashurst get the call up for O2’s listing”
Deal watch: Corporate activity in October 2016
CC and Davis Polk On $8bn China IPO: Davis Polk & Wardwell advised Postal Savings Bank of China on its Hong Kong Stock Exchange float, with Clifford Chance leading for the underwriting banks, including JP Morgan Chase and Goldman Sachs. King & Wood Mallesons acted as Chinese counsel to the banks, while Haiwen & Partners was Chinese adviser to Postal Savings Bank.
Continue reading “Deal watch: Corporate activity in October 2016”
South African sell-down: Slaughters leads as GSK exits Aspen Pharmacare
Slaughter and May, Cleary Gottlieb Steen & Hamilton and Bowman Gilfillan advised GlaxoSmithKline (GSK) on the sale of its remaining 6.2% stake in Aspen Pharmacare, announced last week.
Continue reading “South African sell-down: Slaughters leads as GSK exits Aspen Pharmacare”
Freshfields leads for longtime client Henderson Group on $6bn merger
Freshfields Bruckhaus Deringer and Skadden, Arps, Slate, Meagher & Flom have guided global asset manager Henderson Group and Denver-based global investment firm Janus Capital Group through its $6bn merger.
Continue reading “Freshfields leads for longtime client Henderson Group on $6bn merger”
Skadden, Freshfields and Clifford Chance provide cover as Deustche Bank sells insurer for £935m
Skadden, Arps, Slate, Meagher & Flom, Freshfields Bruckhaus Deringer, Clifford Chance and have all won places advising on Phoenix Group Holdings’ proposed £935m acquisition of life insurance company Abbey Life from Deutsche Bank.
Travers, Debevoise and Freshfields provide cover for $1.1bn Ascot insurance deal
Usual suspects Travers Smith, Debevoise & Plimpton, and Freshfields Bruckhaus Deringer have been gifted with advisory roles on the latest heavyweight deal as Canada Pension Plan Investment (CPPIB) has agreed to buy Ascot Underwriting Holdings, the Lloyds of London insurer linked to American International Group (AIG), as part of a $1.1bn agreement.
Continue reading “Travers, Debevoise and Freshfields provide cover for $1.1bn Ascot insurance deal”
Media matters: CC, Kirkland and Jones Day act on $1.56bn Informa bid for US publisher
Clifford Chance (CC), Kirkland & Ellis and Jones Day have all won mandates on FTSE 100 publishing company Informa’s $1.56bn bid for US trade publisher Penton Business Media.
Clifford Chance and Davis Polk deliver $8bn Hong Kong IPO for Postal Savings Bank
Clifford Chance, Davis Polk & Wardwell, King & Wood Mallesons and Chinese law firm Haiwen & Partners have advised on the year’s largest initial public offering (IPO) of $8bn for Postal Savings Bank of China launched today (14 September).
Continue reading “Clifford Chance and Davis Polk deliver $8bn Hong Kong IPO for Postal Savings Bank”